FIBROBLAST AND NEUTROPHIL COLLAGENASES CLEAVE AT 2 SITES IN THE CARTILAGE AGGRECAN INTERGLOBULAR DOMAIN

FOSANG AJ, LAST K, KNAUPER V, NEAME PJ, MURPHY G, HARDINGHAM TE, Tschesche H, HAMILTON JA (1993)
BIOCHEMICAL JOURNAL 295: 273-276.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ;
Abstract / Bemerkung
The actions of recombinant human fibroblast collagenase (MMP1), purified polymorphonuclear leucocyte collagenase (MMP8) and their N-terminal catalytic domain fragments against cartilage aggrecan and an aggrecan GI-G2 fragment have been investigated in vitro. After activation with recombinant human stromelysin and trypsin, both collagenases were able to degrade human and porcine aggrecans to a similar extent. An N-terminal G1-G2 fragment (150 kDa) was used to identify specific cleavage sites occurring within the proteinase-sensitive interglobular domain between G1 and G2. Two specific sites were found; one at an Asn341-Phe342 bond and another at Asp441-Leu442 (human sequence). This specificity of the collagenases for aggrecan G1-G2 was identical with that of the truncated metalloproteinase matrilysin (MMP7), but different from those of stromelysin (MMP3) and the gelatinases (MMP2 or gelatinase A; MMP9 or gelatinase B) which cleave at the Asn-Phe site, but not the Asp-Leu site. In addition, collagenase catalytic fragments lacking C-terminal hemopexin-like domains were tested and shown to exhibit the same specificities for the G1-G2 fragment as the full-length enzymes. Thus the specificity of the collagenases for cartilage aggrecan was not influenced by the presence or absence of the C-terminal domain. Together with our previous findings, the results show that stromelysin-1, matrilysin, gelatinases A and B and fibroblast and neutrophil collagenases cleave at a common, preferred site in the aggrecan interglobular domain, and additionally that both fibroblast and neutrophil collagenases cleave at a second site in the interglobular domain that is not available to stromelysin or gelatinases.
Erscheinungsjahr
Zeitschriftentitel
BIOCHEMICAL JOURNAL
Band
295
Seite(n)
273-276
ISSN
PUB-ID

Zitieren

FOSANG AJ, LAST K, KNAUPER V, et al. FIBROBLAST AND NEUTROPHIL COLLAGENASES CLEAVE AT 2 SITES IN THE CARTILAGE AGGRECAN INTERGLOBULAR DOMAIN. BIOCHEMICAL JOURNAL. 1993;295:273-276.
FOSANG, A. J., LAST, K., KNAUPER, V., NEAME, P. J., MURPHY, G., HARDINGHAM, T. E., Tschesche, H., et al. (1993). FIBROBLAST AND NEUTROPHIL COLLAGENASES CLEAVE AT 2 SITES IN THE CARTILAGE AGGRECAN INTERGLOBULAR DOMAIN. BIOCHEMICAL JOURNAL, 295, 273-276.
FOSANG, A. J., LAST, K., KNAUPER, V., NEAME, P. J., MURPHY, G., HARDINGHAM, T. E., Tschesche, H., and HAMILTON, J. A. (1993). FIBROBLAST AND NEUTROPHIL COLLAGENASES CLEAVE AT 2 SITES IN THE CARTILAGE AGGRECAN INTERGLOBULAR DOMAIN. BIOCHEMICAL JOURNAL 295, 273-276.
FOSANG, A.J., et al., 1993. FIBROBLAST AND NEUTROPHIL COLLAGENASES CLEAVE AT 2 SITES IN THE CARTILAGE AGGRECAN INTERGLOBULAR DOMAIN. BIOCHEMICAL JOURNAL, 295, p 273-276.
A.J. FOSANG, et al., “FIBROBLAST AND NEUTROPHIL COLLAGENASES CLEAVE AT 2 SITES IN THE CARTILAGE AGGRECAN INTERGLOBULAR DOMAIN”, BIOCHEMICAL JOURNAL, vol. 295, 1993, pp. 273-276.
FOSANG, A.J., LAST, K., KNAUPER, V., NEAME, P.J., MURPHY, G., HARDINGHAM, T.E., Tschesche, H., HAMILTON, J.A.: FIBROBLAST AND NEUTROPHIL COLLAGENASES CLEAVE AT 2 SITES IN THE CARTILAGE AGGRECAN INTERGLOBULAR DOMAIN. BIOCHEMICAL JOURNAL. 295, 273-276 (1993).
FOSANG, AJ, LAST, K, KNAUPER, V, NEAME, PJ, MURPHY, G, HARDINGHAM, TE, Tschesche, Harald, and HAMILTON, JA. “FIBROBLAST AND NEUTROPHIL COLLAGENASES CLEAVE AT 2 SITES IN THE CARTILAGE AGGRECAN INTERGLOBULAR DOMAIN”. BIOCHEMICAL JOURNAL 295 (1993): 273-276.

87 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Expression and correlation of matrix metalloproteinase-7 and interleukin-15 in human osteoarthritis.
Tao Y, Qiu X, Xu C, Sun B, Shi C., Int J Clin Exp Pathol 8(8), 2015
PMID: 26464654
Proteases involved in cartilage matrix degradation in osteoarthritis.
Troeberg L, Nagase H., Biochim Biophys Acta 1824(1), 2012
PMID: 21777704
MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.
Durigova M, Nagase H, Mort JS, Roughley PJ., Matrix Biol 30(2), 2011
PMID: 21055468
Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor.
Chockalingam PS, Sun W, Rivera-Bermudez MA, Zeng W, Dufield DR, Larsson S, Lohmander LS, Flannery CR, Glasson SS, Georgiadis KE, Morris EA., Osteoarthritis Cartilage 19(3), 2011
PMID: 21163358
A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs.
Swearingen CA, Chambers MG, Lin C, Marimuthu J, Rito CJ, Carter QL, Dotzlaf J, Liu C, Chandrasekhar S, Duffin KL, Mitchell PG, Durham TB, Wiley MR, Thirunavukkarasu K., Osteoarthritis Cartilage 18(9), 2010
PMID: 20633676
Effects of alendronate on a disintegrin and metalloproteinase with thrombospondin motifs expression in the developing epiphyseal cartilage in rats.
Kim MS, Kim JH, Lee MR, Kang JH, Kim HJ, Ko HM, Choi CH, Jung JY, Koh JT, Kim BK, Oh HK, Kim WJ, Lee EJ, Kim SH., Anat Histol Embryol 38(2), 2009
PMID: 19183348
Composition-function relationships during IL-1-induced cartilage degradation and recovery.
Palmer AW, Wilson CG, Baum EJ, Levenston ME., Osteoarthritis Cartilage 17(8), 2009
PMID: 19281879
Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM-stimulated bovine cartilage.
Durigova M, Soucy P, Fushimi K, Nagase H, Mort JS, Roughley PJ., Osteoarthritis Cartilage 16(10), 2008
PMID: 18372197
Association between promoter -1607 polymorphism of MMP1 and lumbar disc disease in Southern Chinese.
Song YQ, Ho DW, Karppinen J, Kao PY, Fan BJ, Luk KD, Yip SP, Leong JC, Cheah KS, Sham P, Chan D, Cheung KM., BMC Med Genet 9(), 2008
PMID: 18439317
Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
Struglics A, Larsson S, Pratta MA, Kumar S, Lark MW, Lohmander LS., Osteoarthritis Cartilage 14(2), 2006
PMID: 16188468
Matrix metalloproteinases are not essential for aggrecan turnover during normal skeletal growth and development.
Little CB, Meeker CT, Hembry RM, Sims NA, Lawlor KE, Golub SB, Last K, Fosang AJ., Mol Cell Biol 25(8), 2005
PMID: 15798221
Thrombomodulin enhances the invasive activity of mouse mammary tumor cells.
Niimi S, Harashima M, Takayama K, Hara M, Hyuga M, Seki T, Ariga T, Kawanishi T, Hayakawa T., J Biochem 137(5), 2005
PMID: 15944410
Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.
Janusz MJ, Little CB, King LE, Hookfin EB, Brown KK, Heitmeyer SA, Caterson B, Poole AR, Taiwo YO., Osteoarthritis Cartilage 12(9), 2004
PMID: 15325638
Cartilage degradation independent of MMP/aggrecanases.
Sugimoto K, Iizawa T, Harada H, Yamada K, Katsumata M, Takahashi M., Osteoarthritis Cartilage 12(12), 2004
PMID: 15564068
Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation.
Little CB, Hughes CE, Curtis CL, Janusz MJ, Bohne R, Wang-Weigand S, Taiwo YO, Mitchell PG, Otterness IG, Flannery CR, Caterson B., Matrix Biol 21(3), 2002
PMID: 12009333
Matrix metalloproteinases in arthritic disease.
Murphy G, Knäuper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I., Arthritis Res 4 Suppl 3(), 2002
PMID: 12110122
Induction of osteoarthritis in the rat by surgical tear of the meniscus: Inhibition of joint damage by a matrix metalloproteinase inhibitor.
Janusz MJ, Bendele AM, Brown KK, Taiwo YO, Hsieh L, Heitmeyer SA., Osteoarthritis Cartilage 10(10), 2002
PMID: 12359164
Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M.
Elliott S, Rowan AD, Carrère S, Koshy P, Catterall JB, Cawston TE., Ann Rheum Dis 60(2), 2001
PMID: 11156550
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
Tortorella MD, Malfait AM, Deccico C, Arner E., Osteoarthritis Cartilage 9(6), 2001
PMID: 11520168
Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
Stracke JO, Fosang AJ, Last K, Mercuri FA, Pendás AM, Llano E, Perris R, Di Cesare PE, Murphy G, Knäuper V., FEBS Lett 478(1-2), 2000
PMID: 10922468
Characterization of 5'-flanking region of human aggrecanase-1 (ADAMTS4) gene.
Mizui Y, Yamazaki K, Kuboi Y, Sagane K, Tanaka I., Mol Biol Rep 27(3), 2000
PMID: 11254106
Generation and characterization of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity.
Arner EC, Pratta MA, Trzaskos JM, Decicco CP, Tortorella MD., J Biol Chem 274(10), 1999
PMID: 10037754
Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis.
van Meurs JB, van Lent PL, Holthuysen AE, Singer II, Bayne EK, van den Berg WB., Arthritis Rheum 42(6), 1999
PMID: 10366105
Increased vulnerability of postarthritic cartilage to a second arthritic insult: accelerated MMP activity in a flare up of arthritis.
van Meurs JB, van Lent PL, van de Loo AA, Holthuysen AE, Bayne EK, Singer II, van den Berg WB., Ann Rheum Dis 58(6), 1999
PMID: 10340959
Aggrecanase. A target for the design of inhibitors of cartilage degradation.
Arner EC, Pratta MA, Decicco CP, Xue CB, Newton RC, Trzaskos JM, Magolda RL, Tortorella MD., Ann N Y Acad Sci 878(), 1999
PMID: 10415722
Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
van Meurs J, van Lent P, Stoop R, Holthuysen A, Singer I, Bayne E, Mudgett J, Poole R, Billinghurst C, van der Kraan P, Buma P, van den Berg W., Arthritis Rheum 42(10), 1999
PMID: 10524678
Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, Caterson B., Biochem J 344 Pt 1(), 1999
PMID: 10548534
Pharmacological effect of tetracyclines on proteoglycanases from interleukin-1-treated articular cartilage.
Steinmeyer J, Daufeldt S, Taiwo YO., Biochem Pharmacol 55(1), 1998
PMID: 9413935
Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction.
Mudgett JS, Hutchinson NI, Chartrain NA, Forsyth AJ, McDonnell J, Singer II, Bayne EK, Flanagan J, Kawka D, Shen CF, Stevens K, Chen H, Trumbauer M, Visco DM., Arthritis Rheum 41(1), 1998
PMID: 9433876
Interleukin-1 receptor antagonist prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis.
van Meurs JB, van Lent PL, Singer II, Bayne EK, van de Loo FA, van den Berg WB., Arthritis Rheum 41(4), 1998
PMID: 9550473
Membrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan interglobular domain.
Fosang AJ, Last K, Fujii Y, Seiki M, Okada Y., FEBS Lett 430(3), 1998
PMID: 9688535
An aggrecan-degrading activity associated with chondrocyte membranes.
Billington CJ, Clark IM, Cawston TE., Biochem J 336 ( Pt 1)(), 1998
PMID: 9806902
Matrix metalloproteinase digestion of aggrecan in human cartilage tumours.
Toriyama M, Rosenberg AE, Mankin HJ, Fondren T, Treadwell BV, Towle CA., Eur J Cancer 34(12), 1998
PMID: 10023324
Pathogenesis and treatment of osteoarthritis.
Kraus VB., Med Clin North Am 81(1), 1997
PMID: 9012756
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
Chandler S, Miller KM, Clements JM, Lury J, Corkill D, Anthony DC, Adams SE, Gearing AJ., J Neuroimmunol 72(2), 1997
PMID: 9042108
Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors.
Bottomley KM, Borkakoti N, Bradshaw D, Brown PA, Broadhurst MJ, Budd JM, Elliott L, Eyers P, Hallam TJ, Handa BK, Hill CH, James M, Lahm HW, Lawton G, Merritt JE, Nixon JS, Röthlisberger U, Whittle A, Johnson WH., Biochem J 323 ( Pt 2)(), 1997
PMID: 9163342
Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase.
Verheijen JH, Nieuwenbroek NM, Beekman B, Hanemaaijer R, Verspaget HW, Ronday HK, Bakker AH., Biochem J 323 ( Pt 3)(), 1997
PMID: 9169591
Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander LS., J Clin Invest 100(1), 1997
PMID: 9202061
Aggrecan degradation in human intervertebral disc and articular cartilage.
Sztrolovics R, Alini M, Roughley PJ, Mort JS., Biochem J 326 ( Pt 1)(), 1997
PMID: 9337874
Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen II-induced arthritis.
Singer II, Scott S, Kawka DW, Bayne EK, Weidner JR, Williams HR, Mumford RA, Lark MW, McDonnell J, Christen AJ, Moore VL, Mudgett JS, Visco DM., Osteoarthritis Cartilage 5(6), 1997
PMID: 9536289
Osteoarthritic lesions: involvement of three different collagenases.
Shlopov BV, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA., Arthritis Rheum 40(11), 1997
PMID: 9365097
Activation of human neutrophil procollagenase by stromelysin 2.
Knäuper V, Murphy G, Tschesche H., Eur J Biochem 235(1-2), 1996
PMID: 8631328
Proteoglycan-degrading activity of human stromelysin-1 and leukocyte elastase in rabbit joints. Quantitation of proteoglycan and a stromelysin-induced HABR fragment of aggrecan in synovial fluid and cartilage.
Olszewski JM, Moore VL, McDonnell J, Williams H, Saphos CA, Green BG, Knight WB, Chapman KT, Hagmann WK, Dorn CP, Hale JJ, Mumford RA., Connect Tissue Res 33(4), 1996
PMID: 8834447
Aggrecan: A Target Molecule of Autoimmune Reactions.
Buzás EI, Mikecz K, Glant TT., Pathol Oncol Res 2(4), 1996
PMID: 11173607
Degradation of cartilage aggrecan by collagenase-3 (MMP-13).
Fosang AJ, Last K, Knäuper V, Murphy G, Neame PJ., FEBS Lett 380(1-2), 1996
PMID: 8603731
Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions.
Wilson CL, Matrisian LM., Int J Biochem Cell Biol 28(2), 1996
PMID: 8729000
Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase.
Cole AA, Chubinskaya S, Schumacher B, Huch K, Szabo G, Yao J, Mikecz K, Hasty KA, Kuettner KE., J Biol Chem 271(18), 1996
PMID: 8631924
Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media.
Beekman B, Drijfhout JW, Bloemhoff W, Ronday HK, Tak PP, te Koppele JM., FEBS Lett 390(2), 1996
PMID: 8706864
Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.
Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, Ferrans VJ, Travis WD., Am J Pathol 149(4), 1996
PMID: 8863673
Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain.
Lark MW, Gordy JT, Weidner JR, Ayala J, Kimura JH, Williams HR, Mumford RA, Flannery CR, Carlson SS, Iwata M., J Biol Chem 270(6), 1995
PMID: 7852317
Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
Lark MW, Williams H, Hoernner LA, Weidner J, Ayala JM, Harper CF, Christen A, Olszewski J, Konteatis Z, Webber R., Biochem J 307 ( Pt 1)(), 1995
PMID: 7717983
VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.
Singer II, Kawka DW, Bayne EK, Donatelli SA, Weidner JR, Williams HR, Ayala JM, Mumford RA, Lark MW, Glant TT., J Clin Invest 95(5), 1995
PMID: 7537757
Mouse aggrecan, a large cartilage proteoglycan: protein sequence, gene structure and promoter sequence.
Watanabe H, Gao L, Sugiyama S, Doege K, Kimata K, Yamada Y., Biochem J 308 ( Pt 2)(), 1995
PMID: 7772024
Degradation of vitronectin by matrix metalloproteinases-1, -2, -3, -7 and -9.
Imai K, Shikata H, Okada Y., FEBS Lett 369(2-3), 1995
PMID: 7544295
Use of an antibody against the matrix metalloproteinase-generated aggrecan neoepitope FVDIPEN-COOH to assess the effects of stromelysin in a rabbit model of cartilage degradation.
Bayne EK, MacNaul KL, Donatelli SA, Christen A, Griffin PR, Hoerrner LA, Calaycay JR, Ayala JM, Chapman K, Hagmann W., Arthritis Rheum 38(10), 1995
PMID: 7575690
Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican?
Perides G, Asher RA, Lark MW, Lane WS, Robinson RA, Bignami A., Biochem J 312 ( Pt 2)(), 1995
PMID: 8526845
Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.
Fosang AJ, Last K, Neame PJ, Murphy G, Knäuper V, Tschesche H, Hughes CE, Caterson B, Hardingham TE., Biochem J 304 ( Pt 2)(), 1994
PMID: 7998967

41 References

Daten bereitgestellt von Europe PubMed Central.

Fragmentation of human polymorphonuclear-leucocyte collagenase.
Knauper V, Osthues A, DeClerck YA, Langley KE, Blaser J, Tschesche H., Biochem. J. 291 ( Pt 3)(), 1993
PMID: 8489511
Comparison of human stromelysin and collagenase by cloning and sequence analysis.
Whitham SE, Murphy G, Angel P, Rahmsdorf HJ, Smith BJ, Lyons A, Harris TJ, Reynolds JJ, Herrlich P, Docherty AJ., Biochem. J. 240(3), 1986
PMID: 3030290
The immunologic relationship of human neutrophil and skin collagenases.
Hasty KA, Stricklin GP, Hibbs MS, Mainardi CL, Kang AH., Arthritis Rheum. 30(6), 1987
PMID: 2440453
Levels of metalloproteases and tissue inhibitor of metalloproteases in human osteoarthritic cartilage.
Dean DD, Azzo W, Martel-Pelletier J, Pelletier JP, Woessner JF Jr., J. Rheumatol. 14 Spec No(), 1987
PMID: 3305939
Fragments of human fibroblast collagenase. Purification and characterization.
Clark IM, Cawston TE., Biochem. J. 263(1), 1989
PMID: 2557822
The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis.
Hasty KA, Reife RA, Kang AH, Stuart JM., Arthritis Rheum. 33(3), 1990
PMID: 2156511
Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases.
Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL., J. Biol. Chem. 265(20), 1990
PMID: 2164002
Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase.
Mallya SK, Mookhtiar KA, Gao Y, Brew K, Dioszegi M, Birkedal-Hansen H, Van Wart HE., Biochemistry 29(47), 1990
PMID: 2176876
Sequence specificities of human fibroblast and neutrophil collagenases.
Netzel-Arnett S, Fields GB, Birkedal-Hansen H, Van Wart HE, Fields G., J. Biol. Chem. 266(11), 1991
PMID: 1849891
Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins.
Fosang AJ, Neame PJ, Hardingham TE, Murphy G, Hamilton JA., J. Biol. Chem. 266(24), 1991
PMID: 1874716
Mercurial activation of human polymorphonuclear leucocyte procollagenase.
Blaser J, Knauper V, Osthues A, Reinke H, Tschesche H., Eur. J. Biochem. 202(3), 1991
PMID: 1662606
Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury.
Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW., Arthritis Rheum. 35(1), 1992
PMID: 1370619
Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.
Fairbanks G, Steck TL, Wallach DF., Biochemistry 10(13), 1971
PMID: 4326772
The collagen substrate specificity of human skin fibroblast collagenase.
Welgus HG, Jeffrey JJ, Eisen AZ., J. Biol. Chem. 256(18), 1981
PMID: 6270089
Collagenase and collagenolytic activity in human osteoarthritic cartilage.
Pelletier JP, Martel-Pelletier J, Howell DS, Ghandur-Mnaymneh L, Enis JE, Woessner JF Jr., Arthritis Rheum. 26(1), 1983
PMID: 6297508
Collagenolytic activity and collagen matrix breakdown of the articular cartilage in the Pond-Nuki dog model of osteoarthritis.
Pelletier JP, Martel-Pelletier J, Altman RD, Ghandur-Mnaymneh L, Howell DS, Woessner JF Jr., Arthritis Rheum. 26(7), 1983
PMID: 6870969
Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis.
Wilhelm SM, Eisen AZ, Teter M, Clark SD, Kronberger A, Goldberg G., Proc. Natl. Acad. Sci. U.S.A. 83(11), 1986
PMID: 3012533
Purification of human collagenases with a hydroxamic acid affinity column.
Moore WM, Spilburg CA., Biochemistry 25(18), 1986
PMID: 3021211
Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain.
Allan JA, Hembry RM, Angal S, Reynolds JJ, Murphy G., J. Cell. Sci. 99 ( Pt 4)(), 1991
PMID: 1770006
The role of the C-terminal domain in collagenase and stromelysin specificity.
Murphy G, Allan JA, Willenbrock F, Cockett MI, O'Connell JP, Docherty AJ., J. Biol. Chem. 267(14), 1992
PMID: 1315762
Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium.
Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, Bayliss MT, Iwata K, Nagase H., Lab. Invest. 66(6), 1992
PMID: 1602738
The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.
Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G, Hamilton JA., J. Biol. Chem. 267(27), 1992
PMID: 1326552
The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity.
Schnierer S, Kleine T, Gote T, Hillemann A, Knauper V, Tschesche H., Biochem. Biophys. Res. Commun. 191(2), 1993
PMID: 8460992

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 8216228
PubMed | Europe PMC

Suchen in

Google Scholar